<p>The present invention relates to methods for treating cancer comprising administering an anti-VEGF (vascular endothelial growth factor) monoclonal antibody (e.g. Avastin) and a N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer-TNP-470 conjugate (e.g. Caplostatin) to a patient in need thereof.</p>
申请公布号
WO2006084054(A2)
申请公布日期
2006.08.10
申请号
WO2006US03712
申请日期
2006.02.02
申请人
CHILDREN'S MEDICAL CENTER CORPORATION;FOLKMAN, JUDAH;SATCHI-FAINARO, RONIT
